Anticardiolipin antibodies in two elderly subpopulations

Abstract

Previous studies have reported that the prevalence of certain autoantibodies is nonspecifically elevated in elderly subjects due to immunoscenescence. This study was undertaken to assess the prevalence of anticardiolipin antibodies (aCL) in two elderly subpopulations: Two hundred and eighteen elderly were included in this study; 63 healthy elderly had a prevalence of anticardiolipin antibodies of zero; 155 unselected frail elderly were prospectively evaluated and the prevalence of anticardiolipin antibodies in this group was found to be significantly increased at 18.7%. Subdivision of this group into those elderly clinically assessed as suffering from dementia showed a prevalence of 26.5% and stroke a prevalence of 31.6%. Both were found to be statistically significantly increased when compared with both the healthy and frail elderly population. Subdivision of the dementia patients into those suffering from multi-infarct type dementia (MID) and those suffering from Alzheimer's type dementia (AD) showed an association of 44% and 20%, respectively. The association of MID with aCL was significant. This study demonstrates therefore that anticardiolipin antibodies are not nonspecifically elevated in elderly subjects but are significantly elevated in elderly subjects with strokes and multiple infarct dementia.

Keywords

Anticardiolipin antibodies elderly stroke dementia

Get full access to this article

View all access options for this article.

References

Conley CL , Hartman C. A haemorrhagic disorder caused by circulating anticoagulants in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621-622.

Asherson RA et al. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Balt) 1989; 68: 366-373.

Briley D. , Coull BM , Goodnight SH Neurological disease associated with antiphospholipid antibodies. Ann Neurol 1989; 25: 221-227.

Levine SR et al. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40: 1181-1189.

Levine SR et al. Ischemic stroke associated with anticardiolipin antibodies. Stroke 1987; 18: 1101-1106.

Coull BM et al. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke 1987; 18: 1107-1112.

Leach IH , Lennox G. , Jaspan T. Antiphospholipid antibody syndrome presenting with complex partial seizures and transient ischaemic attackes due to widespread small cerebral arterial thrombosis. Neuropathol Appl Neurobiol 1989 ; 15: 579-584.

Landi G. et al. Recurrent ischemic attacks in two young adults with lupus anticoagulant . Stroke 1983; 14: 377-389.

Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993; 43: 2069-2073.

10.

Vaarala O. et al. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986; 41: 8-15.

11.

Cohen AJ , Philips TM , Kessler CM Circulating coagulation inhibitors in the acquired immunodeficiency syndrome . Ann Intern Med 1986; 104: 175-180.

12.

Manoussakis MN et al. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.

13.

Manoussakis MN et al. Soluble interleukin 2 receptors and autoantibodies in the serum of healthy elderly individuals. Autoimmunity 1990; 7: 129-137.

14.

Juby AG et al. Prevalence of selected autoantibodies in different elderly populations . Br J Rheumatol 1994; 33: 1121-1124.

15.

Chakravarty KK et al. Prevalence of anticardiolipin antibodies in the elderly British population. Postgrad Med J 1991; 67: 358-361.

16.

Loizou S. et al. Measurement of anticardiolipin antibodies by an enzyme linked immunosorbent (ELISA) standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-745.

17.

Stewart MW et al. Detection of antiphospholipid antibodies by flow cytometry: rapid detection of antibody isotype and phospholipid specificity. Thromb Hemost 1993; 70: 603-607.

18.

Silvestris F. et al. Discrepancy in the expression of autoantibodies in healthy aged individuals. Clin Immunol Immunopathol 1985; 35: 234-244.

19.

McElhaney JE , Meneilly GS , Lechelt KE Antibody response to whole-virus and split-virus influenza vaccines in successful aging. Vaccine 1993; 11: 1055-1960.

20.

Verrier Jones J et al. Antiphospholipid antibodies in a healthy population: methods for estimating the distribution. J Rheumatol 1995; 22: 55-61.

21.

Chakravarty KK et al. Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus. Q J Med 1991; 79, no. 289: 397-405.

22.

Lopez OL et al. Serum autoantibodies in patients with Alzheimer's disease and vascular dementia and in nondemented control subjects. Stroke 1992; 23: 1078-1083.

23.

Westerman EM et al. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Arthritis Rheum 1992; 35: 1038-1041.

24.

Skias D. et al. Senile dementia of Alzheimer's type (SDAT): reduced T8+-cell-mediated suppressor activity. Neurology 1985; 35: 1635-1638.

25.

Leffell MS , Lumsdear L. , Steiger WA An analysis of T lymphocyte subpopulations in patients with Alzheimer's disease . J Am Geriatr Soc 1985; 33: 4-7.

26.

Singh VK , Fudenberg HH Detection of brain auto-antibodies in the serum of patients with Alzheimer's disease but not Down's syndrome. Immunol Lett 1986; 123: 277-280.

27.

Gaskin F. , Kingsley BS , Fu SM Auto-antibodies to neurofibrillary angles and brain tissue in Alzheimer's disease: establishment of Epstein-Barr virus-transformed antibody producing cell lines. J Exp Med 1987; 165: 245-250.

28.

Fillit HM et al. Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type. J Gerontol 1987; 42: 180-184.

29.

Michaelson DM et al. Serum antibodies to cholinergic neurons in Alzheimer's disease. Prog Clin Biol Res 1989; 317: 689-694.

30.

Fillit HM et al. Auto-immunity to cholinergic-specific antigens of the brain in senile dementia of the Alzheimer's type. Drug Dev Res 1988; 15: 1-9.